NURA Expands South India Presence with Launch of Preventive Health Screening Centre in Chennai

IMT News Desk
IMT News Desk
· 2 min read
NURA opens a new AI-enabled preventive health screening centre in Chennai, expanding its South India presence and boosting access to early disease detection.

NURA, an advanced diagnostic venture between Fujifilm Healthcare and Dr Kutty’s Healthcare, has expanded its footprint in South India with the launch of its preventive health screening centre in Chennai.

Located in Egmore, the facility marks NURA’s sixth centre in India and reflects the company’s continued focus on expanding access to advanced preventive healthcare and early disease detection services.

The facility was inaugurated in the presence of senior leadership from Fujifilm, NURA and Dr Kutty’s Healthcare, including Mr Jun Higuchi (Corporate Vice President and General Manager of Medical Division, FUJIFILM Corporation), Mr Nobuo Matsunobe (Managing Director, NURA), Mr Koji Wada (Managing Director, FUJIFILM India) and Mr Masaharu Morita (Founder & Programme Director, NURA).

The Chennai launch marks an important milestone in NURA’s India expansion journey. Designed to offer AI-enabled full-body health screenings, the Chennai facility integrates advanced imaging and diagnostic technologies to support faster detection of diseases at early stages. The centre has the capacity to screen up to 40 guests per day.

Commenting on the development, Mr Masaharu Morita, Founder and Programme Director, NURA, said: “India continues to be a key country in NURA’s global expansion journey, and Chennai marks an important step in strengthening our South India presence. With growing awareness around lifestyle diseases and preventive healthcare, there is a rising need for advanced screening infrastructure. Through our AI-driven screening ecosystem and Fujifilm’s healthcare innovations, we aim to deliver efficient and accessible preventive healthcare services.”

Following the Chennai launch, NURA continues to pursue an ambitious expansion roadmap focused on strengthening its presence across Tier 1, Tier 2, and emerging urban areas in India. Internationally, the company is also exploring opportunities across the Middle East and Africa,  South Asia and ASEAN as part of its larger vision to establish a strong and accessible global preventive healthcare network.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk